These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1737542)

  • 21. A randomized study comparing blood glucose control and risk of severe hypoglycemia achieved by non-programmable versus programmable external insulin pumps.
    Catargi B; Breilh D; Gin H; Rigalleau V; Saux MC; Roger P; Tabarin A
    Diabetes Metab; 2001 Jun; 27(3):323-7. PubMed ID: 11431597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Implantable insulin pumps: evaluation after more than 3 years experience].
    Keipes M; Michel G; Pinget M
    Bull Soc Sci Med Grand Duche Luxemb; 1994; 131(1):17-30. PubMed ID: 8050116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
    Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
    Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type II diabetic patients poorly controlled with sulfonylureas.
    Jennings AM; Lewis KS; Murdoch S; Talbot JF; Bradley C; Ward JD
    Diabetes Care; 1991 Aug; 14(8):738-44. PubMed ID: 1954811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
    Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
    Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symptoms, hormones, and glucose fluxes during a gradual hypoglycaemia induced by intraperitoneal vs venous insulin infusion in Type I diabetes.
    Selam JL; Medlej R; M'bemba J; Chevalier A; Guyon F; Ashworth L; Slama G
    Diabet Med; 1995 Dec; 12(12):1102-9. PubMed ID: 8750221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study.
    Dassau E; Renard E; Place J; Farret A; Pelletier MJ; Lee J; Huyett LM; Chakrabarty A; Doyle FJ; Zisser HC
    Diabetes Obes Metab; 2017 Dec; 19(12):1698-1705. PubMed ID: 28474383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. The EVADIAC Study Group. Evaluation dans le Diabète du Traitement par Implants Actifs.
    Hanaire-Broutin H; Broussolle C; Jeandidier N; Renard E; Guerci B; Haardt MJ; Lassmann-Vague V
    Diabetes Care; 1995 Mar; 18(3):388-92. PubMed ID: 7555483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between sensor-augmented insulin therapy with continuous subcutaneous insulin infusion or multiple daily injections in everyday life: 3-day analysis of glucose patterns and sensor accuracy in children.
    Zucchini S; Scipione M; Balsamo C; Maltoni G; Rollo A; Molinari E; Mangoni L; Cicognani A
    Diabetes Technol Ther; 2011 Dec; 13(12):1187-93. PubMed ID: 21854193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of blood glucose stability and HbA1C between implantable insulin pumps using U400 HOE 21PH insulin and external pumps using lispro in type 1 diabetic patients: a pilot study.
    Catargi B; Meyer L; Melki V; Renard E; Jeandidier N;
    Diabetes Metab; 2002 Apr; 28(2):133-7. PubMed ID: 11976565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion.
    Weintrob N; Schechter A; Benzaquen H; Shalitin S; Lilos P; Galatzer A; Phillip M
    Arch Pediatr Adolesc Med; 2004 Jul; 158(7):677-84. PubMed ID: 15237068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up.
    van Dijk PR; Logtenberg SJ; Groenier KH; Gans RO; Kleefstra N; Bilo HJ
    BMC Endocr Disord; 2014 Apr; 14():30. PubMed ID: 24708696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implantable programmable insulin pumps for the treatment of diabetes.
    Waxman K; Turner D; Nguyen ST; Selam JL; Charles MA
    Arch Surg; 1992 Sep; 127(9):1032-6; discussion 1036-7. PubMed ID: 1387526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.
    Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J
    Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implanted constant basal rate insulin infusion devices for Type 1 (insulin-dependent) diabetic patients.
    Kritz H; Hagmüller G; Lovett R; Irsigler K
    Diabetologia; 1983 Aug; 25(2):78-81. PubMed ID: 6628877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial.
    Feig DS; Corcoy R; Donovan LE; Murphy KE; Barrett JFR; Sanchez JJ; Wysocki T; Ruedy K; Kollman C; Tomlinson G; Murphy HR;
    Diabetes Care; 2018 Dec; 41(12):2471-2479. PubMed ID: 30327362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Impact of Continuous Subcutaneous Insulin Infusion Therapy on Efficacy and Safety in a Cohort of Type 1 Diabetes Patients: A 3-Year Prospective Study.
    Melidonis A; Kamaratos A; Angelidi A; Thomakos P; Vrakas S; Bakalis J; Fousteris E; Iraklianou S
    Diabetes Technol Ther; 2016 Mar; 18(3):159-63. PubMed ID: 26862678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps.
    Melki V; Renard E; Lassmann-Vague V; Boivin S; Guerci B; Hanaire-Broutin H; Bringer J; Belicar P; Jeandidier N; Meyer L; Blin P; Augendre-Ferrante B; Tauber JP
    Diabetes Care; 1998 Jun; 21(6):977-82. PubMed ID: 9614617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in NIDDM.
    Bagdade JD; Kelley DE; Henry RR; Eckel RH; Ritter MC
    Diabetes; 1997 Mar; 46(3):414-20. PubMed ID: 9032097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.